The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...
ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.
Stool-based screening for colorectal cancer may be sharper in women than in men, and the reason traces back to sex-specific ...
Through trend analyses, this surveillance highlighted both the emergence and decline of AMR across diverse bacterial pathogens, helping inform which antibiotics may remain appropriate as first-line ...
On July 17, 2025, the American Heart Association published a science advisory formally connecting the composition of gut ...
Add Yahoo as a preferred source to see more of our stories on Google. Before HR stepped in, being an executive assistant often meant running your boss's stool sample to the doctor or handling their ...
Cases of a diarrhea-causing intestinal parasite have exploded in Michigan over the last two weeks in an outbreak that still ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide availability of ColoSense®, the only RNA-based at-home test for colorectal ...
The Rome V criteria for IBS identified a different group of patients, with lower sensitivity than either Rome III or IV ...
Golden monkeys grooming each other in Rwanda's Volcanoes National Park. The eDNA can be used to develop a list of all species in the country, which in turn will help protect biodiversity. — Photos: AP ...